YANOCSMXXDFQIM-UHFFFAOYSA-N
C37H46F2N10O4S — CID 139421614
Data last refreshed: (MolForge compound catalog, from PubChem)
About YANOCSMXXDFQIM-UHFFFAOYSA-N
YANOCSMXXDFQIM-UHFFFAOYSA-N (PubChem CID 139421614) has the molecular formula C37H46F2N10O4S and a molecular weight of 764.90 g/mol. Its IUPAC name is N-[3-[5-cyclopropylsulfanyl-2-(difluoromethoxy)phenyl]-1-[3-[4-[[4-[2-(dimethylamino)-2-oxoethyl]piperazin-1-yl]methyl]piperidin-1-yl]-3-oxopropyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.
Molecular Properties
| Compound Name | YANOCSMXXDFQIM-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 139421614 |
| Molecular Formula | C37H46F2N10O4S |
| Molecular Weight | 764.90 g/mol |
| Exact Mass | 764.34 |
| IUPAC Name | N-[3-[5-cyclopropylsulfanyl-2-(difluoromethoxy)phenyl]-1-[3-[4-[[4-[2-(dimethylamino)-2-oxoethyl]piperazin-1-yl]methyl]piperidin-1-yl]-3-oxopropyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
| SMILES | CN(C)C(=O)CN1CCN(CC2CCN(C(=O)CCn3cc(NC(=O)c4cnn5cccnc45)c(-c4cc(SC5CC5)ccc4OC(F)F)n3)CC2)CC1 |
| InChI | InChI=1S/C37H46F2N10O4S/c1-44(2)33(51)24-46-18-16-45(17-19-46)22-25-8-13-47(14-9-25)32(50)10-15-48-23-30(42-36(52)29-21-41-49-12-3-11-40-35(29)49)34(43-48)28-20-27(54-26-4-5-26)6-7-31(28)53-37(38)39/h3,6-7,11-12,20-21,23,25-26,37H,4-5,8-10,13-19,22,24H2,1-2H3,(H,42,52) |
| InChIKey | YANOCSMXXDFQIM-UHFFFAOYSA-N |
| XLogP | 4.04 |
| TPSA | 133.44 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 54 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 764.90 |
| LogP ≤ 5 | 4.04 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139421614 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.